Get the Stockscreener App
7.65
0.39%
0.03
Pre-market:
7.65
Anteris Technologies Global Corp stock is traded at $7.65, with a volume of 777.77K.
It is up +0.39% in the last 24 hours and down -13.07% over the past month.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
See More
Previous Close:
$7.62
Open:
$7.6
24h Volume:
777.77K
Relative Volume:
0.77
Market Cap:
$745.56M
Revenue:
$1.85M
Net Income/Loss:
$-95.19M
P/E Ratio:
-3.4447
EPS:
-2.2208
Net Cash Flow:
$-86.88M
1W Performance:
-9.14%
1M Performance:
-13.07%
6M Performance:
+41.93%
1Y Performance:
+72.69%
1-Day Range:
$7.47
$7.6953
1-Week Range:
$7.47
$8.57
52-Week Range:
$3.30
$11.05
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
7.65 | 745.56M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-11-26 | Initiated | Wells Fargo | Overweight |
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
View All
Anteris Technologies Global Corp Stock (AVR) Latest News
Anteris Extends Key Supply and Quality Agreement Term - The Globe and Mail
Anteris Technologies Global Extends Supply & Quality Agreement With Harvey Industries Group Through 2026 - TradingView
Anteris Technologies Global Corp.(ASX:AVR) dropped from S&P/ASX Emerging Companies Index - marketscreener.com
What Is Behind Anteris Technologies Global Corp (ASX:AVR) ASX Healthcare Stocks Attention? - Kalkine Media
Anteris Technologies Grants Contingent Stock Options to CEO Wayne Paterson and CFO David St Denis - kalkine.com.au
Anteris Technologies approves equity grants for Wayne Paterson, David St Denis and Matthew McDonnell - TradingView
Anteris (AVR) ties new executive stock awards to $61.50 share hurdle - Stock Titan
Olin Share PriceOLN, RNS News, Articles, Quotes, & Charts (NYSE:OLN) - Proactive financial news
Anteris (AVR) awards CFO 90K stock options expiring 2036 - Stock Titan
Anteris Technologies (AVR) CFO discloses zero shares in first ownership filing - Stock Titan
Anteris Technologies Global (ASX:AVR) Clinical Update: DurAVR Trial, Funding and Operations - kalkine.com.au
Anteris Technologies Global Appoints New Chief Financial Officer - The Globe and Mail
Anteris Appoints Brent Moen as Chief Financial Officer - Minichart
Anteris Technologies appoints Brent Moen as CFO; Matthew McDonnell to Head of Australia - TradingView
Anteris Technologies Global Corp. Announces Appointment of Matthew McDonnell as Head of Australia , Effective September 11, 2026 - marketscreener.com
Anteris Technologies Global Corp. Announces CFO Changes, Effective September 11, 2026 - marketscreener.com
Why Is AVR (ASX:AVR) Drawing Attention After a Key Finance Move? - Kalkine Media
Anteris Technologies Names Brent Moen as New CFO Effective September 2026 - Kalkine Media
Anteris Technologies Global CorpAppoints B - Moomoo
Anteris Technologies Names CFO; Shares Up 4% - marketscreener.com
Anteris reshapes finance leadership with new CFO appointment - TipRanks
Anteris Technologies appoints Brent Moen as chief financial officer - Proactive financial news
Anteris Technologies Appoints Brent Moen as Chief Financial Officer - Kalkine
Anteris Technologies Global names new CFO - grafa.com
L1 Capital Pty Ltd Trims Anteris Technologies Global Corp (AVR) Stake in Recent 13DG Filing - GuruFocus
Anteris Technologies Global Corp Reports August 2026 CDI and Securities on Issue Statement - kalkine.com.au
L1 Capital Pty Ltd Sells 7,800 Shares of Anteris Technologies Global Corp. (NASDAQ: AVR) - Kalkine Media
L1 Capital sells 7,800 Anteris shares at $8.83 - Stock Titan
Anteris to Present at September Healthcare Investor Conferences - The Manila Times
Should I Buy AVR? AVR 2026 AnalysisIntellectia AI™ - Intellectia AI
AVR Q1 2026 Earnings: EPS Misses Estimates with Wider -$0.28 Loss, Stock Edges Up 0.67%Profit Guidance Range - careplusvn.com
Anteris Technologies (AVR) COO exercises 60K options, withholds 45K shares - Stock Titan
Anteris (AVR) Quarterly Scorecard: EPS Misses Its Estimate in Latest Trading; The Stock Gains 1.70% on the DayInvestor Earnings Call - vinanet.vn
L1 Capital Pty Ltd Trims Anteris Technologies Global Corp (AVR) Stake Amid Strong Rally - GuruFocus
Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Anteris Technologies Global (NASDAQ:AVR) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
L1 Capital Pty Ltd Expands Stake in Anteris Technologies Global Corp (AVR) with Significant Share Acquisition - GuruFocus
Anteris Technologies Global Corp. (ASX:AVR) Share Price Falls 4.05% as Stock Trades Within Daily Range - Kalkine
Anteris Technologies Global (NASDAQ:AVR) Shares Down 4.3% Following Weak Earnings - MarketBeat
L1 Capital Executes Two-Day Sale of Over 627,000 Anteris Technologies Shares - Kalkine Media
Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 251,844 Shares of Stock - MarketBeat
L1 Capital Pty Ltd Sells 375,815 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock - MarketBeat
L1 Capital (AVR) reports 627,659-share sale and sizable CDI, warrant stakes - Stock Titan
AVR:ASX AnnouncementQuarterly Results Announcement and SEC Form 10-Q12 Aug 2026 - Market Index
Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR - MarketBeat
Anteris Technologies Q2 Loss Narrows, Net Sales Rise - marketscreener.com
Anteris Technologies Reports Q2 2026 Results With PARADIGM Trial Expansion and U.S. Medicare Reimbursement Secured - kalkine.com.au
Why Is Anteris Technologies Global (ASX:AVR) Drawing Fresh Attention Among ASX Healthcare Stocks? - Kalkine Media
Anteris Technologies Q2 loss widens, sales miss estimates - scanx.trade
Anteris Technologies Global Corp. Reports Second Quarter 2026 Financial Results - Kalkine
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):